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Drug-resistant tuberculosis (TB) caused byMycobacterium tu-berculosis is a global threat and amajor public health problem
in several countries (1). In South Africa, circulatingM. tuberculo-
sis strains are diverse (2), with three spoligotypes beingmost com-
mon: the Beijing spoligotype predominant in Western Cape, and
the Euro-American LAM4 and S spoligotypes predominant in
Gauteng and KwaZulu-Natal (KZN) provinces (3). The Euro-
American S spoligotype (ST34) is prevalent in TB patients within
KZN and Gauteng provinces (4).
We describe the draft genome sequences of two extensively
drug-resistant (XDR) TB clinical strains ofM. tuberculosis belong-
ing to ST34. Permission to use these strains was granted by the
University of Pretoria, Faculty of Health Sciences, Research Ethics
Committee (206/2012). Both strains, RSA184 and RSA114, were
isolated from patients from Swaziland. Spoligotyping and drug
susceptibility testing (DST) were performed per standard proto-
cols (5, 6).
DNA was extracted from heat-killed M. tuberculosis grown
on slants, using a previously described chemical method (7).
Illumina sequencing libraries were prepared as previously de-
scribed (8) and sequenced using the Illumina HiSeq platform at
the Broad Institute (Cambridge, MA, USA). Reads from
RSA114 and RSA184 were assembled into draft genomes using
ALLPATHS-LG with Pilon (9). The genome assemblies of
4,416,700 bp and 4,389,272 bp for RSA114 and RSA 184, re-
spectively, were annotated by aligning each assembly to the
H37Rv genome (CP003248.2) using Nucmer (10). For those
genes not cleanly mapping to H37Rv, the protein-coding genes
of 4,020 and 4,019 for RSA 114 and RSA 184, respectively, were
predicted with Prodigal (9). Both strains had 45 tRNAs identi-
fied by tRNAscan-SE (11) and 3 rRNA genes predicted using
RNAmmer (12). We also confirmed the experimental spoligo-
type predictions using a previously described computational
spoligotyping approach (13).
Sequence reads were aligned to theM. tuberculosisH37Rv ref-
erence genome using BWA (14), and Pilon was used to identify
variants. We detected a total of 797 and 734 nonsynonymous
changes relative to H37Rv for RSA114 and RSA184, respectively.
We also detected nonsynonymous changes in rpoB (S450L,
I491F), katG (S315T), and gyrA (D94G), previously implicated in
drug resistance. Interestingly, RSA114, which lacked known
resistance-conferring gyrA mutations, had 14, 7, and 4 nonsyn-
onymous changes in genes encoding efflux pumps (EPs), phthio-
cerol dimycocerosates (PDIMs) and type VII secretion systems
(ESXs), respectively. Drug resistance inM. tuberculosis can be ac-
quired through mutations in EPs that increase their activity to
expel a broad spectrumof antibiotics (15), and ofloxacin-resistant
strains, lacking DNA gyrasemutations, were found to overexpress
EPs (16). In RSA114, we identified mutations within the EP-
encoding genes Rv0987, Rv2039c, and Rv0402c that are predicted
by PROVEAN (http://provean.jcvi.org/index.php), to impact ef-
flux activity. ESX export enzymes are involved in the synthesis of
PDIM proteins, which have a role in virulence (17), and are over-
expressed in XDR TB strains, suggesting a contribution to this
XDR-level drug resistance (18). Future functional studies are
needed to determine the impact of these mutations on drug resis-
tance.
Nucleotide sequence accession numbers. The whole-genome
sequences for RSA114 and RSA184 have been deposited at NCBI
GenBank under the accession numbers JKJF01000000 and
JKQQ01000000, respectively.
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